 send to a friend by email
2023-02-14
According to the financial statements of Jerusalem Pharmaceuticals Company JPH for year 2022, Net profit after tax of the period reached 7,268,480 USD Compared with Net profit after tax 6,218,251 USD for 2021, a net increase in profit of 16.89%.Total assets of the company reached 81,088,974 USD compared with total assets of 86,892,982 USD at the end of year 2021, a net decrease of 6.68%.Total liabilities of the company reached 16,470,223 USD compared with total liabilities of 18,323,461 USD at the end of year 2021, a net decrease of 10.11%. Net ownership equity of the company reached 64,618,751 USD (Including Non-Controlling Interests of 938,779 USD) compared with total owner equity of 68,569,521 USD (Including Non-Controlling Interests of 2,097,384 USD) at the end of year 2021, a net decrease of 5.76%.
|
-trade
